Carboplatin and paclitaxel, alone and in combination: Dose escalation, measurement of renal function, and role of the p53 tumor suppressor gene

Seminars in Oncology

Volumn 26, Issue 1 SUPPL. 2, 1999, Pages 90-94

  Calvert, A H ^a   Ghokul, S ^a   Al Azraqi, A ^a   Wright, J ^a   Lind, M ^a   Bailey, N ^a   Highley, M ^a   Siddiqui, N ^a   Lunec, J ^a   Sinha, D ^a   Boddy, A ^a   Roberts, T ^a   Fenwick, J ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; PACLITAXEL; PROTEIN P53;

CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CREATININE BLOOD LEVEL; GENE SEQUENCE; GLOMERULUS FILTRATION RATE; HUMAN; NEUTROPENIA; OVARY CANCER; PRIORITY JOURNAL; THROMBOCYTOPENIA; TUMOR SUPPRESSOR GENE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AREA UNDER CURVE; CARBOPLATIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; GENES, P53; HUMANS; KIDNEY FUNCTION TESTS; OVARIAN NEOPLASMS; PACLITAXEL;

EID: 0033041769     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)